Oxford Immunotec (OXFD) Reports Q4 EPS of $0.33, Slight Miss on Revenues

Note: EPS may not be comparable

Oxford Immunotec (NASDAQ: OXFD) reported Q4 EPS of $0.33, versus ($0.18) reported last year. Revenue for the quarter came in at $25 million versus the consensus estimate of $25.65 million.

• Net income for the fourth quarter of 2017 was $8.8 million, or $0.33 per share on a diluted basis, compared to a net loss $4.9 million, or $0.22 per share in the fourth quarter of 2016.
• Revenue for the fourth quarter of 2017 was $25.0 million, representing 6% growth over the fourth quarter 2016 revenue of $23.7 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c